US Patent 12006361 Albumin binding domain fusion proteins

Patent 12006361 was granted and assigned to Sonnet Biotherapeutics, Inc. on June, 2024 by the United States Patent and Trademark Office.

Currently, there are no issues on this topic.

Find more entities like US Patent 12006361 Albumin binding domain fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.